UK’s top gambling operator GVC Holdings is hosting a symposium on research into safer gambling. The symposium is about discussing the progress of partnership with the Cambridge Health Alliance, a Harvard Medical School.
The gambling operator had forged a $5.5 million multi-year partnership supporting Cambridge Health’s ‘Division of Addiction’ faculty.
Commenting on the symposium, GVC’s CEO Kenneth Alexander said: “As part of our Changing for the Bettor strategy, we at GVC are determined to advance the understanding of problem gambling so that we can more successfully intervene to minimize harm to potentially vulnerable individuals. Our partnership with Harvard Medical School’s Division on Addiction is vital to this process and we are delighted to be hosting today’s symposium to bring together so many people who share our ambition.”
Completing its first year of critical research, GVC will showcase the work of Professors Dr Debi LaPlante and Dr Sarah E. Nelson at the British Academy.
Dr. Debi LaPlante, Director at the Division of Addiction of the Cambridge Health Alliance, Harvard Medical School added: “It is only by taking an evidence-based approach to examining gambling that we can develop better strategies and tools to limit its potential to cause harm.
The collaboration with GVC that is at the heart of today’s symposium will play a significant role in advancing our knowledge about the issue of problem gambling and is warmly welcomed.”
Gambling addiction has been on the rise in the UK. According to a recent report, the number of children at risk of gambling addiction in the country has risen by 400 percent over the past two years.